hero section gradient
16 handpicked stocks

Natural Gas Drilling Revival Play

A carefully selected group of stocks poised to benefit from the recent upturn in U.S. natural gas drilling activity. Our professional analysts have identified companies across the entire natural gas value chain that could see improved performance as drilling rebounds for the first time in twelve weeks.

Author avatar

Han Tan | Market Analyst

Published on July 20

Your Basket's Financial Footprint

Summary and investor takeaways for a basket focused on natural gas drilling-related companies, based on provided market capitalisation data.

Key Takeaways for Investors:
  • Large-cap concentration tends to reduce volatility, offering generally more stable, lower-risk returns versus smaller-cap, high-growth baskets.
  • Suitable as a core holding for diversified portfolios, not primarily a speculative growth allocation.
  • Expect steadier, long-term value appreciation; less likely to deliver explosive, short-term gains.
Total Market Cap
  • EQT: $34.77B

  • LNG: $48.84B

  • RRC: $8.76B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection targets companies benefiting from renewed natural gas drilling, with rig counts at their highest since March 2024. The increase signals a potential bottom in the drilling downturn and shifting capital allocation toward natural gas assets, creating opportunities across the entire value chain.

2

What You Need to Know

Drilling activity serves as a leading indicator of future production. This theme offers exposure to companies that may see improved utilization rates, pricing power, and cash flow generation as activity levels normalize after twelve weeks of decline.

3

Why These Stocks

These companies were specifically chosen to capture different segments of the natural gas industry: exploration and production companies with key basin assets, service providers offering essential drilling capabilities, and midstream operators that handle transportation infrastructure.

Why You'll Want to Watch These Stocks

🔄

Riding the Reversal Wave

After twelve straight weeks of declining rig counts, the natural gas sector is showing signs of a comeback. This could be your chance to get in at what might be the bottom of the cycle.

📊

Early Indicator Advantage

Drilling activity is a leading indicator of future energy production. By investing now, you could position yourself ahead of broader market recognition of this trend shift.

⛓️

Full Value Chain Exposure

This collection offers exposure to every segment of the natural gas industry, from exploration companies finding the gas to midstream operators moving it to market. It's comprehensive coverage in a single investment theme.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions